From university spin-off to global leader in three decades
QIAGEN was founded by a team of scientists from Heinrich Heine University in Düsseldorf, Germany, in 1984. Within two years they launched a new method of obtaining genetic material from cells for further analysis that was much easier to use, faster and more reliable than previous methods. This ready-to-use kit reduced processing time from several days to a few hours. This enabled molecular biology processes to be conducted in laboratories all over the world, and not just in universities. Since then, QIAGEN has never stopped growing through the development of new sample and assay technologies.
That small team of university scientists has now grown into a global workforce of more than 4,700. Our global headquarters is in Venlo, The Netherlands, and we have over 35 subsidiaries in more than 20 countries and sales offices in 70 countries. With more than 500 products in our portfolio, we market a broad range of consumables and instruments to meet the varied needs of over 500,000 customers across a variety of markets in healthcare and the life sciences. Our success is based, not least, on the fact that we invest around 10% of our sales in R&D to continuously drive innovation and growth.